Trial intelligence / Profile preview

Randomized single-center study of fusidic acid, hyaluronic acid repair biofilm, and Lactobacillus preparation for bacterial balanoposthitis

ChiCTR1800016901Phase 4Recruiting

Sponsor
First Hospital of China Medical University
Start
Jul 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of fusidic acid and hyaluronic acid in balanoposthitis (3 arms), sponsored by First Hospital of China Medical University. Primary endpoints: Skin barrier function and Skin flora. Started Jul 2018; status: recruiting.

02

Drugs

fusidic acidhyaluronic acid
03

Conditions

balanoposthitis

Beyond the preview

Go deeper on ChiCTR1800016901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800016901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call